Correction: Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease (Journal of the American College of Cardiology (2013) 61(4) (427–436), (S0735109712055222), (10.1016/j.jacc.2012.08.1026));Remnant cholesterol as a causal risk factor for ischemic heart disease

Journal of the American College of Cardiology

Volumn 61, Issue 4, 2013, Pages 427-436

  Varbo, Anette ^a,b   Benn, Marianne ^a,b   Tybjærg Hansen, Anne ^a,b,c,d   Jørgensen, Anders B ^a,b,c   Frikke Schmidt, Ruth ^a,b,c   Nordestgaard, Børge G ^a,b,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

atherosclerosis; cardiovascular disease; lipoproteins; myocardial infarction

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REMNANT CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABCA1 GENE; ADULT; AGED; APOA5 GENE; APOB GENE; ARTICLE; CONTROLLED STUDY; DENMARK; FEMALE; GCKR GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LDLR GENE; LIPC GENE; LPL GENE; MAJOR CLINICAL STUDY; MALE; PCSK9 GENE; PRIORITY JOURNAL; RISK FACTOR; TRIB1 GENE;

EID: 84872675457     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2019.01.006     Document Type: Erratum

References (43)

1. B.G. Nordestgaard, M. Benn, P. Schnohr, A. Tybjærg-Hansen Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 2007 299 308
2. M.J. Chapman, H.N. Ginsberg, P. Amarenco Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management Eur Heart J 32 2011 1345 1361
3. A. Langsted, J.J. Freiberg, A. Tybjærg-Hansen, P. Schnohr, G.B. Jensen, B.G. Nordestgaard Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up J Intern Med 270 2011 65 75
4. A. Varbo, B.G. Nordestgaard, A. Tybjærg-Hansen, P. Schnohr, G.B. Jensen, M. Benn Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population Ann Neurol 69 2011 628 634
5. S. Bansal, J.E. Buring, N. Rifai, S. Mora, F.M. Sacks, P.M. Ridker Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 298 2007 309 316
6. M. Miller, N.J. Stone, C. Ballantyne Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association Circulation 123 2011 2292 2333
7. J.J. Freiberg, A. Tybjærg-Hansen, J.S. Jensen, B.G. Nordestgaard Nonfasting triglycerides and risk of ischemic stroke in the general population JAMA 300 2008 2142 2152
8. E. Di Angelantonio, N. Sarwar, P. Perry Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 2009 1993 2000
9. B.G. Nordestgaard, A. Langsted, J.J. Freiberg Nonfasting hyperlipidemia and cardiovascular disease Curr Drug Targets 10 2009 328 335
10. B.G. Nordestgaard, A. Tybjærg-Hansen Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk Curr Opin Lipidol 22 2011 113 122
11. P.J. Barter, M. Caulfield, M. Eriksson Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122
12. W.E. Boden, J.L. Probstfield, T. Anderson Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
13. D.A. Lawlor, R.M. Harbord, J.A. Sterne, N. Timpson, S.G. Davey Mendelian randomization: using genes as instruments for making causal inferences in epidemiology Stat Med 27 2008 1133 1163
14. G.D. Smith, N. Timpson, S. Ebrahim Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization Ann Med 40 2008 524 541
15. R. Clarke, M. Shipley, S. Lewington Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 1999 341 353
16. J.C. Cohen, E. Boerwinkle, T.H. Mosley Jr, H.H. Hobbs Sequence variations in PCSK9, low LDL, and protection against coronary heart disease N Engl J Med 354 2006 1264 1272
17. M. Benn, B.G. Nordestgaard, P. Grande, P. Schnohr, A. Tybjærg-Hansen PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses J Am Coll Cardiol 55 2010 2833 2842
18. M. Shaikh, R. Wootton, B.G. Nordestgaard Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans Arterioscler Thromb 11 1991 569 577
19. B.G. Nordestgaard, R. Wootton, B. Lewis Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo Molecular size as a determinant of fractional loss from the intima-inner media Arterioscler Thromb Vasc Biol 15 1995 534 542
20. K. Nakajima, T. Nakano, A. Tanaka The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma Clin Chim Acta 367 2006 36 47
21. S. Devaraj, G. Vega, R. Lange, S.M. Grundy, I. Jialal Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease Am J Med 104 1998 445 450
22. K. Sakata, N. Miho, M. Shirotani, H. Yoshida, Y. Takada, A. Takada Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery Atherosclerosis 136 1998 225 231
23. H. Masuoka, K. Ishikura, S. Kamei Predictive value of remnant-like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease Am Heart J 136 1998 226 230
24. S. Takeichi, N. Yukawa, Y. Nakajima Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death Atherosclerosis 142 1999 309 315
25. H. Masuoka, S. Kamei, H. Wagayama Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels Am Heart J 139 2000 305 310
26. H. Masuoka, S. Kamei, M. Ozaki Predictive value of remnant-like particle cholesterol as an indicator of coronary artery stenosis in patients with normal serum triglyceride levels Intern Med 39 2000 540 546
27. J. Song, H. Park, S.H. Hong, H.K. Lee, Y.B. Park, J.Q. Kim Remnant-like particle cholesterol levels in Korean patients with coronary artery disease and non-insulin dependent diabetes mellitus Clin Chem Lab Med 38 2000 427 432
28. F. Karpe, S. Boquist, R. Tang, G.M. Bond, U. de Faire, A. Hamsten Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides J Lipid Res 42 2001 17 21
29. K. Oi, H. Shimokawa, Y. Hirakawa Postprandial increase in plasma concentrations of remnant-like particles: an independent risk factor for restenosis after percutaneous coronary intervention J Cardiovasc Pharmacol 44 2004 66 73
30. T. Inoue, T. Uchida, H. Kamishirado Remnant-like lipoprotein particles as risk factors for coronary artery disease in elderly patients Horm Metab Res 36 2004 298 302
31. K. Miwa, T. Makita, K. Ishii, N. Okuda, A. Taniguchi High remnant lipoprotein levels in patients with variant angina Clin Cardiol 27 2004 338 342
32. K. Kugiyama, H. Doi, K. Takazoe Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease Circulation 99 1999 2858 2860
33. J.R. McNamara, P.K. Shah, K. Nakajima Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study Atherosclerosis 154 2001 229 236
34. H. Fukushima, K. Kugiyama, S. Sugiyama Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease Am J Cardiol 88 2001 1370 1373
35. H. Fukushima, S. Sugiyama, O. Honda Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus J Am Coll Cardiol 43 2004 2219 2224
36. T. Nakamura, H. Takano, K. Umetani Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome Atherosclerosis 181 2005 321 327
37. A. Varbo, M. Benn, A. Tybjærg-Hansen, P. Grande, B.G. Nordestgaard TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population Arterioscler Thromb Vasc Biol 31 2011 451 457
38. S. Kathiresan, O. Melander, C. Guiducci Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans Nat Genet 40 2008 189 197
39. R. Frikke-Schmidt, B.G. Nordestgaard, M.C. Stene Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease JAMA 299 2008 2524 2532
40. C.L. Haase, A. Tybjærg-Hansen, A.A. Qayyum, J. Schou, B.G. Nordestgaard, R. Frikke-Schmidt LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals J Clin Endocrinol Metab 97 2012 E248 E256
41. T.H. Johannsen, P.R. Kamstrup, R.V. Andersen Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease J Clin Endocrinol Metab 94 2009 1264 1273
42. B.F. Voight, G.M. Peloso, M. Orho-Melander Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study Lancet 380 2012 572 580
43. A. Tybjærg-Hansen, R. Steffensen, H. Meinertz, P. Schnohr, B.G. Nordestgaard Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease N Engl J Med 338 1998 1577 1584